鐘文昭

個人簡介

每年主刀肺癌微創手術八百餘台，曾獲2016年中國醫師協會胸外科醫師手術技藝大賽中國冠軍、2016年AME國際單孔胸腔鏡肺葉切除比賽亞軍、2015年中日韓肺癌個體化診療大賽總決賽冠軍;獲2019年度“雙青人才計畫”的傑出青年人才(400萬)和廣東省首批“登峰計畫”項目資助(1000萬)。以第一完成人獲2020年廣東省科學技術進步獎一等獎，獲第十六屆廣東省丁穎科技獎。

主要研究方向為以肺癌外科為主單病種多學科綜合治療，包括腫瘤分子克隆演化、局部晚期肺癌圍術期治療、肺部孤立結節/肺腺癌分類診斷和管理、人工智慧型影像-液體活檢肺癌早篩分診系統等;主持四項國家自然科學基金，獲 2019年度“雙青計畫”的傑出青年人才和廣東省首批“登峰計畫”項目資助。系列研究結果發表在Lancet Oncol(IF 41.3)，J Clin Oncol(IF 44.5)(3 篇), Nat Commun(IF 14.9), J Thorac Oncol(IF 15.6)(7篇)，J Extracell Vesicles(IF 25.8)等國際高水平期刊，對國內外肺癌診療具有影響力和推動作用。

國際肺癌研究協會（IASLC）2022年度Tsuguo Naruke外科獎，該獎項代表獲獎者對肺癌研究的全球年度學術/外科技術發展作出了主要貢獻；2016年、2020年兩屆世界肺癌大會早中期肺癌外科專場主席和中國肺癌臨床指南執筆專家。參與2016-2018年《中國臨床腫瘤學會原發性肺癌診療指南》制定，共同主編《細支氣管肺泡癌》、《肺腺癌病理新分類和臨床實踐》，參編高級衛生專業技術資格考試指導用書《臨床腫瘤學高級教程》，研究生衛生部規劃教材《胸心外科學》肺腺癌新分類和肺癌個體化外科章節。肺癌異質性、圍術期TKI治療和臨床研究合作等課題在14th/15th 世界肺癌大會、2018年歐洲腫瘤年會（ESMO）等國際肺癌會議上受邀口頭髮言，受邀擔任2016年、 2020年兩屆世界肺癌大會早中期肺癌外科專場主席。

2023年6月，當選國際肺癌聯盟理事。

發表論文

Wen-Zhao Zhong#; Qun Wang; Wei-Min Mao; Song-Tao Xu; Lin Wu; Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-Yang Liu, Qing Zhou, Yi-Long Wu,Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial,Journal of Clinical Oncology, 2021, 39(7):713-722 (IF=44.544);
Si-Yang Liu, Hua Bao , Qun Wang, Wei-Min Mao, Yedan Chen, Xiaoling Tong, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen Shi-Dong Xu , Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Song Dong, Xu-Chao Zhang, Jian Su, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Xue Wu, Yang Shao, Wen-Zhao Zhong*, Yi-Long Wu*; Genomic signatures define three subtypes of EGFR-mutant stage II–IIInon-small-cell lung cancer with distinct adjuvant therapy outcomes, Nature Communications,2021, 12(1):6450 (IF=14.919);
Wen-Fang Tang, Min Wu, Hua Bao, Yang Xu, Jie-Shan Lin, Yi Liang, Yu Zhang, Xiang-Peng Chu, Zhen-Bin Qiu, Jian Su, Jia-Tao Zhang, Chao Zhang, Fang-Ping Xu, Jing-Hua Chen, Rui Fu, Ying Chen, Tao Yang, Qing-Ke Chen, Ting-Ting Wu, Xue Wu, Yang Shao 1, Jian-Tao Zheng 1, Zhi Xie, Zhi-Yi Lv, Song Dong, Yi-Long Wu, Wen-Zhao Zhong*, Timing and origins of local and distant metastases in lung cancer,Journal of Thoracic Oncology, 2021, 16(7):1136-1148 (IF=15.609);
Chao Zhang#, Kai Yin#, Si-Yang Liu#, Li-Xu Yan, Jian Su, Yi-Long Wu, Xu-Chao Zhang, Wen-Zhao Zhong*, Xue-Ning Yang*, Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy, Journal for Immunotherapy of Cancer, 2021,9:e002312 (IF=13.754);
Jin Kang#, Chao Zhang, Wen-Zhao Zhong*, Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art,Cancer Communications, 2021,41(4):287-302 (IF=10.392);
Xiang-Peng Chu, Zi-Hao Chen1, Shao-Min Lin, Jia-Tao Zhang, Zhao-Wen Qiu, Wen-Fang Tang, Rui Fu, Zhen-Bin Qiu, Xue-Ning Yang, Yi-Long Wu, Qiang Nie*, Wen-Zhao Zhong*, Watershed analysis of the target pulmonary artery for real-time localization of non-palpable pulmonary nodules,Translational Lung Cancer Research, 2021,10(4):1711-1719 (IF=6.498);
Zhen-Bin Qiu#, Chao Zhang, Xiang-Peng Chu, Fei-Yue Cai, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Quantifying invasiveness of clinical stage IA lung adenocarcinoma with computed tomography texture features,Journal of Thoracic and Cardiovascular Surgery, 2021, S0022-5223(20)33447-4 (IF=5.209);
Xiang-Peng Chu#, Zi-Hao Chen#, Shao-Min Lin, Wen-Fang Tang, Jia-Tao Zhang, Yao-Ming Lai, Rui Fu, Zhen-Bin Qiu, Jun-Tao Lin, Qiang Nie, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Precise resection of multiple pulmonary nodules using a three-dimensional reconstruction model: A case report, Thoracic Cancer, 2021, 12(6):970-973(IF=3.5);
Rui Fu, Chao Zhang, Tao Zhang, Xiang-Peng Chu, Wen-Fang Tang, Xue-Ning Yang, Mei-Ping Huang, Jian Zhuang, Yi-Long Wu, Wen-Zhao Zhong*, A three-dimensional printing navigational template combined with mixed reality technique for localizing pulmonary nodules, Interactive cardiovascular and thoracic surgery, 2021, 32(4):552-559 (IF=1.903);
Chao Zhang#, Li-Xu Yan, Ben-Yuan Jiang, Yi-Long Wu, Wen-Zhao Zhong*,Feasibility and Safety of Neoadjuvant Alectinib in a Patient With ALK-Positive Locally Advanced NSCLC, Journal of Thoracic Oncology,2020, 15(6):e95-e99 (IF=15.609);
Wen-Fang Tang#, Qing-Yi Hou#, Jun-Tao Lin#, Dong-Jiang Li#, Jie-Shan Lin, Jing-Hua Chen, Zhen-Bin Qiu, Xiang-Peng Chu , Xiong-Wen Yang, Hong--hong Yan, Shu-xia Wang, Yi-long Wu, Wen-zhao Zhong*, A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer,Frontiers in Oncology, 2020, 2;10:1503 (IF=6.244);
Jia-Tao Zhang#, Ye Li#, Li-Xu Yan, Zheng-Fei Zhu, Xiao-Rong Dong, Qian Chu, Lin Wu, Hong-Mei Zhang, Chun-Wei Xu, Gen Lin, Zong-Yang Yu, Jie Hu, Bo Zhu, Hui-Juan Wang, Fan Yang, Zheng-Bo Song, Zheng-Bo Han, Meng-Xia Li, Jie Lin, Yi-Long Wu, Jin-Liang Wang*, Wen-Zhao Zhong*,Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: a multi-center retrospective study,Lung Cancer,2020, 139:118-123 (IF=5.705);
Wen-Fang Tang#, Wen-Zhao Zhong*, ASO Author Reflections: Lung Adenocarcinoma with Accidental Invisible Pleural Dissemination Lesions:Wait-and-See Strategy for Tumors with Indolent Biologic Characteristics
Ying Chen#, Wen-Fang Tang#, Huan Lin, Hua Bao, Wei Li, Ao Wang, Xue Wu, Jian Su, Jie-Shan Lin, Yang W. Shao, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*.Invisible Pleural Dissemination Lesions: Wait-and-See Strategy for Tumors with Indolent Biologic Characteristics,Annals of surgical oncology, 2020, 27(10):3819-3820 (IF=5.344);
Ying Chen#, Wen-Fang Tang#, Huan Lin, Hua Bao, Wei Li, Ao Wang, Xue Wu, Jian Su, Jie-Shan Lin, Yang W. Shao, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival, Annals of surgical oncology, 2020, 27(10):3808-3818 (IF=5.344);
Jia-Tao Zhang#, Song Dong, Xiang-Peng Chu, Shao-Min Lin, Run-Ying Yu,Ben-Yuan Jiang, Ri-Qiang Liao, Qiang Nie, Hong-Hong Yan, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Randomized Trial of an Improved Drainage Strategy vs Routine Chest Tube after Lung Wedge Resection,Annals of Thoracic Surgery, 2020, 109(4):1040-1046 (IF=4.33);
Jing-Hua Chen, Xiang-Peng Chu, Jia-Tao Zhang, Qiang Nie, Wen-Fang Tang, Jian Su, Hong-Hong Yan, Hong-Ping Zheng, Ze-Xin Chen, Xin Chen, Meng-Meng Song, Xin Yi, Pan-Song Li, Yan-Fang Guan, Gang Li, Chu-Xia Deng, Rafael Rosell, Yi-Long Wu, Wen-Zhao Zhong*,Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients, Thoracic Cancer, 2020, 11(8):2279-2290 (IF=3.5);
Rui Fu, Yun-Fei Chai, Jia-Tao Zhang, Tao Zhang, Xiao-Kun Chen, Song Dong, Hong-Hong Yan, Xue-Ning Yang, Mei-Ping Huang, Yi-Long Wu , Jian Zhuang, Wen-Zhao Zhong*, Three-dimensional printed navigational template for localizing small pulmonary nodules: A case-controlled study,Thoracic Cancer,2020, 11(9):2690-2697 (IF=3.5);
Rui Fu#, LinWu#, Chao Zhang, Qian Chu, JieHu, Gen Lin, Lin Yang, Ji-ShengLi, Xue-NingYang, Jin-JiYang, Qing Zhou, Yi-Long Wu, Wen-Zhao Zhong*,Real-world Scenario of Patients with Lung Cancer Amid the COVID-19 Pandemic in China, JTO Clinical and Research Reports, 2020, 1(3):100053;
Wen-Zhao Zhong#, Ke-Neng Chen, Chun Chen, Chun-Dong Gu, Jun Wang, Xue-Ning Yang, Wei-Min Mao, Qun Wang, Gui-Bin Qiao, Ying Cheng, Lin Xu, Chang-Li Wang, Ming-Wei Chen, Xiao-zheng Kang, Wan-pu Yan, Hong-Hong Yan, MARi-Qiang Liao, Jin-Ji Yang, Xu-Chao Zhang, Qing Zhou, Yi-Long Wu*,Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study,Journal of Clinical Oncology, 2019, 37(25):2235-2245 (IF=44.544);
Jia-Tao Zhang#, Hao Qin, Fiona Ka Man Cheung, Jian Su, Da-Dong Zhang, Shi-Yi Liu, Xiao-Fang Li, Jing Qin, Jun-Tao Lin, Ben-Yuan Jiang, Song Dong, Ri-Qiang Liao, Nie Qiang, Xue-Ning Yang, Hai-Yan Tu, Qing Zhou, Jin-Ji Yang, Xu-Chao Zhang, Ya-Nan Zhang, Yi-Long Wu*, Wen-Zhao Zhong*, Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules,Journal of Extracellular Vesicles, 2019, 8(1):1663666 (IF=25.841);
Chao Zhang#, Natasha B. Leighl, Yi-Long Wu, Wen-Zhao Zhong*, Emerging therapies for non-small cell lung cancer,Journal of Hematology & Oncology,2019,12(1):45(IF=17.388);
Chao Zhang#, Shao-lei Li#, Qiang Nie, Song Dong, Yang Shao, Xue-ning Yang, Yi-long Wu, Yue Yang, Wen-zhao Zhong*, Neoadjuvant Crizotinib in Resectable Locally Advanced Non–Small Cell Lung Cancer with ALK Rearrangement, Journal of Thoracic Oncology, 2019, 14(4):726-731 (IF=15.609);
Song-Tao Xu#, Jun-Jie Xi#, Wen-Zhao Zhong#, Wei-Min Mao, Lin Wu, Yi Shen, Yong-Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Ke Fei, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao M Hong-Hong Yan, BS, Xue-Ning Yang, Yong-Xing Zhang, Jia-Cheng Yin, BS, Qun Wang, Yi-Long Wu*, The unique spatial–temporal treatment failure patterns of adjuvant gefitinib therapy: A post-hoc analysis of the ADJUVANT trial (CTONG 1104), Journal of Thoracic Oncology, 2019, 14(3):503-512 (IF=15.609);
Chao Zhang#, Jianjun Zhang#, Fang-Ping Xu, Yin-Guang Wang, Zhi Xie, Jian Su, Song Dong, Qiang Nie, Yang Shao, Qing Zhou, Jin-Ji Yang, Xue-Ning Yang, Xu-Chao Zhang, Zhi Li, Yi-Long Wu, Wen-Zhao Zhong*, Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma,Journal of Thoracic Oncology,2019, 14(11):1912-1923 (IF=15.609);
Chao Zhang#, Yi-Long Wu, Wen-Zhao Zhong*, Rapid Postoperative Relapse in ALK-Positive Locally Advanced NSCLC Patient with Complete Pathological Response to Neoadjuvant Crizotinib, Journal of Thoracic Oncology, 2019, 14(10):e234-e236 (IF=15.609);
Wen-Fang Tang#, Yuan-Yuan Lei, Jian Su, Chao Zhang, Rui Fu, Jin Kang, Hong-Hong Yan, Xue-Ning Yang, Hai-Yan Tu, Yi-Long Wu, Wen-Zhao Zhong*, TNM stages inversely correlate with the age at diagnosis in ALK-positive lung cancer,Translational lung cancer research,2019,8(2):144-154(IF=6.498);
Zhen-Bin Qiu#, Zihao Chen#, Chao Zhang, Wen-Zhao Zhong*,Achievements and futures of immune checkpoint inhibitors in non‑small cell lung cancer, Experimental Hematology & Oncology, 2019, Aug 22;8:19 (IF=5.133);
Chao Zhang#, Xing Sun#, Kang Dang, Ke Li, Xiao-Wei Guo, Jia Chang, Zong-Qiao Yu, Fei-Yue Huang, Yun-Sheng Wu, Zhu Liang, Zai-Yi Liu, Xue-Gong Zhang, Xing-Lin Gao, Shao-Hong Huang, Jie Qin, Wei-Neng Feng, Tao Zhou, Yan-Bin Zhang, Wei-Jun Fang, Ming-Fang Zhao, Xue-Ning Yang, Qing Zhou, Yi-Long Wu*, Wen-Zhao Zhong*, Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network, The Oncologist, 2019, 24(9): 1159-1165 (IF=5.025);
Jia-Tao Zhang#, Si-Yang Liu, Hong-Hong Yan, Yi-Long Wu, Qiang Nie*, Wen-Zhao Zhong*, Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study, BMC Cancer, 2019, 19(1):1051(IF=4.43);
Rui Fu#, Jia-Tao Zhang, Song Dong, Ying Chen, Chao Zhang, Wen-Fang Tang, Jin Xia, Qiang Nie*, Wen-Zhao Zhong*, Drainage tube hole suture improvement: Removal-free stitches, Thoracic Cancer, 2019, 10(9):1827-1833 (IF=3.5);
Chao Zhang#, Huan Lin#, Rui Fu, Tao Zhang, Qiang Nie, Song Dong, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Application of indocyanine green fluorescence for precision sublobar resection, Thoracic Cancer, 2019, 10(4):624-630(IF=3.5);
Tao Zhang#, Jia-Tao Zhang, Wen-Feng Li, Jun-Tao Lin, Si-Yang Liu, Hong-Hong Yan, Jin-Ji Yang, Xue-Ning Yang, Yi-Long Wu, Qiang Nie*, Wen-Zhao Zhong*,Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study, Journal of Thoracic Disease, 2019, 11(7):2754-2762 (IF=2.895);
Jia-Tao Zhang#, Tao Zhang, Zhao-Wen Qiu, Wen-Zhao Zhong*, Metal-marked mixed reality technology for pulmonary nodule localization,Interactive CardioVascular and Thoracic Surgery, 2019, 29(3):494 (IF=1.905);
Wen-Zhao Zhong#, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yi Shen, Yong-Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Ke Fei, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Xue-Ning Yang, Qing Zhou, Yi-Long Wu*, on behalf of the ADJUVANT investigators,Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study,The Lancet Oncology, 2018, 19(1):139-148 (IF=41.316);
Jia-Tao Zhang#, Yi-Chun Tang#, Jun-Tao Lin, Song Dong, Qiang Nie, Ben-Yuan Jiang, Hong-Hong Yan, Zheng-Wei Wen, Yue Wu, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Prophylactic air-extraction strategy after thoracoscopic wedge resection,Thoracic Cancer, 2018, 9(11):1406-1412 (IF=3.5);
Wen-Zhao Zhong#, Si-Yang Liu, Yi-Long Wu*,Numbers or Stations: From Systematic Sampling to Individualized Lymph Node Dissection in Non–Small-Cell Lung Cancer, Journal of Clinical Oncology, 2017, 35(11):1143-1145(IF=44.544);
Zhong-Yi Dong#, Jia-Tao Zhang#, Si-Yang Liu#, Jian Su, Chao Zhang, Zhi Xie, Qing Zhou, Hai-Yan Tu, Chong-Rui Xu, Li-Xu Yan, Yu-Fa Li, Wen-Zhao Zhong*, Yi-Long Wu*,EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-blockade in non-small cell lung cancer, Oncoimmunology, 2017, 6(11):e1356145 (IF=8.11);
Hao‑Ran Zhai#, Xue‑Ning Yang#, Qiang Nie, Ri‑Qiang Liao, Song Dong, Wei Li, Ben‑Yuan Jiang, Jin‑Ji Yang, Qing Zhou, Hai‑Yan Tu, Xu‑Chao Zhang, Yi‑Long Wu*, Wen‑Zhao Zhong*, Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patients, Chinese Journal of Cancer, 2017, 36(1):53 (IF=5.087);
Zhong-Yi Dong#, Hao-Ran Zhai#, Qing-Yi Hou, Jian Su, Si-Yang Liu, Hong-Hong Yan, Yang-Si Li, Zhi-Yong Chen, Wen-Zhao Zhong*, Yi-Long Wu*,Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer, The Oncologist, 2017, 22(1):61-69 (IF=5.025);
Ying Chen#, Jun-Tao Lin, Song Dong, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Uniportal video-assisted thoracoscopic surgery left upper lobectomy and systematic lymph node dissection with fused fissure,Journal of Thoracic Disease, 2017, 9(5):1375-1381 (IF=2.895);
Jia-Tao Zhang#, Song Dong, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Systemic tunnel dissection of mediastinal lymph nodes without clamping via uniportal video-assisted thoracoscopic surgery, Journal of Thoracic Disease, 2017, 9(9):3272-3274 (IF=2.895);
Xiao-Hua Li#, Tao Zhang#, Sheng Wang, Biao-Chuan He, Xue-Ning Yang, Wen-Zhao Zhong*, Ji-Mei Chen*,Minimally invasive, multi-disciplinary approach for surgical management of a mediastinal congenital bronchogenic cyst in a 6-month-old infant,Journal of Thoracic Disease,2017, 9(9):E743-E747 (IF=2.895);
Jia-Tao Zhang#, Hao-Ran Zhai, Zhong-Yi Dong, Yi-Long Wu, Wen-Zhao Zhong*,What’s new in the treatment of advanced small-cell lung cancer,Translational Cancer Research,2017, 6(3):639-644 (IF=1.241);
Wei Li#, Xue-Ning Yang, Ri-Qiang Liao, Qiang Nie, Song Dong, Hao-Ran Zhai, Yi-Long Wu*, Wen-Zhao Zhong*, Intraoperative frozen sections of the regional lymph nodes contribute to surgical decision-making in non-small cell lung cancer patients, Journal of Thoracic Disease, 2016, 8(8):1974-80 (IF=2.895);
Hao-Ran Zhai#, Qiang Nie, Song Dong, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong*, Right upper lobectomy performed as dividing posterior ascending artery-bronchus-pulmonary vessels is alternative to primary indolent scar carcinomas, Journal of Thoracic Disease, 2016, 8(6):1340-4 (IF=2.895);
Wen-Zhao Zhong#, Xue-Ning Yang#, Hong-Hong Yan, Xu-Chao Zhang, Jian Su, Zhi-Hong Chen, Ri-Qiang Liao, Qiang Nie, Song Dong, Qing Zhou, Jin-Ji Yang, Hai-Yan Tu And Yi-Long Wu*, Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status, Journal of Hematology & Oncology,2015, May 17;8:54 (IF=17.388);
Lan-Ying Gou#, Fei-Yu Niu, Yi-Long Wu, Wen-Zhao Zhong*,Differences in Driver Genes Between Smoking-Related and Non–Smoking-Related Lung Cancer in the Chinese Population,Cancer,2015, 17:3069-79 (IF=6.86);
Wen-Zhao Zhong#, Jian Su, Fang-Ping Xu, Hao-Ran Zhai, Xu-Chao Zhang, Xue-Ning Yang, Zhi-Yong Chen, Zhi-Hong Chen, Wei Li, Song Dong, Qing Zhou, Jin-Ji Yang, Yan-Hui Liu, Yi-Long Wu*, Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers, Lung Cancer, 2015, 90(2):205-11 (IF=5.705);
Feng Li#, Wen-Zhao Zhong#, Fei-Yu Niu, Ning Zhao, Jin-Ji Yang, Hong-Hong Yan, Yi-Long Wu*,Multiple primary malignancies involving lung cancer,BMC Cancer, 2015, 15:1-8 (IF=4.43);
Wen-Zhao Zhong#, Wei Li, Xue-Ning Yang, Ri-Qiang Liao, Qiang Nie, Song Dong, Hong-Hong Yan, Xu-Chao Zhang, Hai-Yan Tu, Bin-Chao Wang, Jian Su, Jin-Ji Yang, Qing Zhou, Yi-Long Wu*, Accidental invisible intrathoracic disseminated pT4-M1a: a distinct lung cancer with favorable prognosis, Journal of Thoracic Disease, 2015, 7(7):1205-12 (IF=2.895);
Ji-Lin Guan#, Wen-Zhao Zhong#, She-Juan An, Jin-Ji Yang, Jian Su, Zhi-Hong Chen, Hong-Hong Yan, Zhi-Yong Chen, Zhi-Min Huang, Xu-Chao Zhang, Qiang Nie, Yi-Long Wu*, KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy,annals of surgical oncology, 2013, 20(4):1381-8 (IF=5.344);
Huan Lin#, Wen-Zhao Zhong#, Xue-Ning Yang, Xu-Chao Zhang, Jin-Ji Yang, Qing Zhou, Hong-Hong Yan, Ri-Qiang Liao, Qiang Nie, Song Dong, Yi-Long Wu*, A Clinical Model to Estimate the Pretest Probability of Lung Cancer, Based on 1198 Pedigrees in China,Journal of Thoracic Oncology, 2012, 7(10):1534-40 (IF=15.609);
Zhi-Yong Chen#, Wen-Zhao Zhong#, Xu-Chao Zhang, Jian Su, Xue-Ning Yang, Zhi-Hong Chen, Jin-Ji Yang, Qing Zhou, Hong-Hong Yan, She-Juan An, Hua-Jun Chen, Ben-Yuan Jiang, Tony S. Mok*, Yi-LongWu*, EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas, The Oncologist, 2012, 17(7):978-85 (IF=5.025);
Wen-Zhao Zhong#, Yi-Long Wu*, Xue-Ning Yang, Ai-Lin Guo, Jian Su, Xu-Chao Zhang, Dong-Lan Luo, Zhen Wang, Hua-Jun Chen, Qing Zhou, Chong-Rui Xu, Gui-Bin Qiao, Ri-Qiang Liao, Jin-Ji Yang, Tony S. Mok, Genetic Evolution of Epidermal Growth Factor Receptor in Adenocarcinoma With a Bronchioloalveolar Carcinoma Component, Clinical Lung Cancer,2010, 11(3):160-8 (IF=4.785);
Wen-zhao Zhong#, Xue-ning Yang, Jian-ling Bai, Jin-ji Yang, Christian Manegold, Yi-long Wu*,Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer, European Journal of Cardio-thoracic Surgery, 2008, 34(1):187-95 (IF=4.191);

鐘文昭

基本介紹

個人簡介

發表論文

擅長領域

所獲榮譽

相關詞條

熱門詞條